Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism

Clinical Endocrinology

Volumn 76, Issue 2, 2012, Pages 246-252

  Ragnarsson, Oskar ^a   Nyström, Helena Filipsson ^a   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE;

ADULT; ARTICLE; BODY WEIGHT; BONE DENSITY; CARDIOVASCULAR RISK; CORTICOTROPIN DEFICIENCY; FEMALE; FEMUR NECK; GLUCOCORTICOID REPLACEMENT THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; BONE DENSITY; BONE DISEASES, METABOLIC; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; MALE; MIDDLE AGED; RISK FACTORS; SEX CHARACTERISTICS;

EID: 84855466080     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04174.x     Document Type: Article

References (32)

1. Sherlock, M., Ayuk, J., Tomlinson, J.W., et al. (2010) Mortality in patients with pituitary disease. Endocrine Reviews, 31, 301-342.
2. Rosen, T., Johannsson, G., Johansson, J.O., et al. (1995) Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper. Hormone Research, 43, 93-99.
3. Wuster, C., Abs, R., Bengtsson, B.A., et al. (2001) The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. Journal of Bone and Mineral Research, 16, 398-405. (Pubitemid 32106717)
4. Holmes, S.J., Economou, G., Whitehouse, R.W., et al. (1994) Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 78, 669-674. (Pubitemid 24083309)
5. Doga, M., Bonadonna, S., Gola, M., et al. (2005) GH deficiency in the adult and bone. Journal of Endocrinological Investigation, 28, 18-23.
6. Filipsson, H., Monson, J.P., Koltowska-Haggstrom, M., et al. (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. Journal of Clinical Endocrinology and Metabolism, 91, 3954-3961. (Pubitemid 44536870)
7. Svensson, J., Bengtsson, B.A., Rosen, T., et al. (2004) Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. Journal of Clinical Endocrinology and Metabolism, 89, 3306-3312. (Pubitemid 38960692)
8. Tomlinson, J.W., Holden, N., Hills, R.K., et al. (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet, 357, 425-431.
9. Bensing, S., Brandt, L., Tabaroj, F., et al. (2008) Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clinical Endocrinology (Oxford), 69, 697-704.
10. Bergthorsdottir, R., Leonsson-Zachrisson, M., Oden, A., et al. (2006) Premature mortality in patients with Addison's disease: a population-based study. Journal of Clinical Endocrinology and Metabolism, 91, 4849-4853. (Pubitemid 44917317)
11. Sherlock, M., Reulen, R.C., Alonso, A.A., et al. (2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 94, 4216-4223.
12. Esteban, N.V., Loughlin, T., Yergey, A.L., et al. (1991) Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 72, 39-45. (Pubitemid 21921653)
13. Danilowicz, K., Bruno, O.D., Manavela, M., et al. (2008) Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary, 11, 279-285.
14. Mah, P.M., Jenkins, R.C., Rostami-Hodjegan, A., et al. (2004) Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clinical Endocrinology (Oxford), 61, 367-375. (Pubitemid 39287067)
15. Gotherstrom, G., Svensson, J., Koranyi, J., et al. (2001) A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. Journal of Clinical Endocrinology and Metabolism, 86, 4657-4665. (Pubitemid 33026070)
16. Friedewald, W.T., Levy, R.I., &, Fredrickson, D.S., (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
17. Zimmet, P., Magliano, D., Matsuzawa, Y., et al. (2005) The metabolic syndrome: a global public health problem and a new definition. Journal of Atherosclerosis Thrombosis, 12, 295-300.
18. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
19. Liddle, G.W., (1961) Clinical pharmacology of the anti-inflammatory steroids. Clinical Pharmacology and Therapeutics, 2, 615-635.
20. Boland, E.W., (1952) Antirheumatic effects of hydrocortisone (free alcohol), hydrocortisone acetate, and cortisone (free alcohol) as compared with cortisone acetate; results from oral administration in patients with rheumatoid arthritis.]. British Medicial Journal, 1, 559-564.
21. Canalis, E., Mazziotti, G., Giustina, A., et al. (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporosis International, 18, 1319-1328. (Pubitemid 47389469)
22. Crown, A., &, Lightman, S., (2005) Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clinical Endocrinology (Oxford), 63, 483-492. (Pubitemid 41626741)
23. Arlt, W., Rosenthal, C., Hahner, S., et al. (2006) Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clinical Endocrinology (Oxford), 64, 384-389.
24. Zelissen, P.M., Croughs, R.J., van Rijk, P.P., et al. (1994) Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Annals of Internal Medicine, 120, 207-210. (Pubitemid 24038804)
25. Florkowski, C.M., Holmes, S.J., Elliot, J.R., et al. (1994) Bone mineral density is reduced in female but not male subjects with Addison's disease. New Zealand Medical Journal, 107, 52-53.
26. Lovas, K., Gjesdal, C.G., Christensen, M., et al. (2009) Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. European Journal of Endocrinology, 160, 993-1002.
27. Peacey, S.R., Guo, C.Y., Robinson, A.M., et al. (1997) Glucocorticoid replacement therapy: are patients over treated and does it matter? Clinical Endocrinology (Oxford), 46, 255-261. (Pubitemid 27174326)
28. Tritos, N.A., Greenspan, S.L., King, D., et al. (2011) Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis. Journal of Clinical Endocrinology and Metabolism, 96, 1516-1523.
29. Dullaart, R.P., Schols, J.L., van der Steege, G., et al. (2008) Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients. Clinical Endocrinology (Oxford), 69, 359-366.
30. Bulow, B., Hagmar, L., Eskilsson, J., et al. (2000) Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. Journal of Clinical Endocrinology and Metabolism, 85, 574-584. (Pubitemid 32279601)
31. Holmer, H., Svensson, J., Rylander, L., et al. (2007) Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone. Journal of Clinical Endocrinology and Metabolism, 92, 3560-3567. (Pubitemid 47439735)
32. Attanasio, A.F., Mo, D., Erfurth, E.M., et al. (2010) Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. Journal of Clinical Endocrinology and Metabolism, 95, 74-81.